Haemonetics 4th Quarter and Fiscal 2019 Earnings Release Available on Investor Relations Website
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil ends week higher on renewed US-Iran strikes, diesel hits record
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Haemonetics (HAE) Tops Q4 EPS by 6c, Offers Guidance, Approves $500M Buyback
May 7, 2019 6:16 AM EDTHaemonetics (NYSE: HAE) reported Q4 EPS of $0.61, $0.06 better than the analyst estimate of $0.55. Revenue for the quarter came in at $249.3 million versus the consensus estimate of $250.63 million.
GUIDANCE:
Haemonetics sees FY2020 EPS of $2.80-$3.00, versus the consensus of $2.89.
SHARE REPURCHASE PROGRAM The Company announced that its Board of Directors recently authorized the repurchase of... More
